Status:
COMPLETED
Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Psoriasis
Psoriatic Arthritis
Eligibility:
All Genders
18-65 years
Brief Summary
The aim of the study is to investigate the link between pro-inflammatory T cells responses arising in the skin in patients with cutaneous psoriasis and those present in the joints of patients developi...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of cutaneous psoriasis without clinical signs of PsA,
- Patients with a diagnosis of PsA
- Healthy subjects with a negative family and personal anamnesis for psoriasis.
- Absence of acute and chronic systemic or cutaneous infections during sample collections.
Exclusion
- Treatment with cyclosporin A, methotrexate, systemic corticosteroids or any other immunosuppressant agent within 3 weeks before the blood samples collections.
Key Trial Info
Start Date :
October 16 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 13 2018
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03374527
Start Date
October 16 2014
End Date
June 13 2018
Last Update
September 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Galeazzi Orthopedic Hospital
Milan, Italy, 20161